Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
Phase II/III Randomized Multicentre Study Comparing Neoadjuvant Chemoradiotherapy Followed by Consolidation Chemotherapy to Neoadjuvant Chemoradiotherapy Alone in Non-metastatic Rectal Cancer Patients.
Sponsor: Al Hada Military Hospital
A PHASE2/PHASE3 clinical study on Rectal Cancer, this trial is ongoing. The trial is conducted by Al Hada Military Hospital and has accumulated 8 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Unknown PHASE2/PHASE3
Status: Recruiting → Unknown
-
Nov 2025 — Dec 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2025 — Nov 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
▶ Show 3 earlier versions
-
May 2022 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — May 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Al Hada Military Hospital
- King Abdullah Medical City
- King Faisal Specialist Hospital & Research Center
- King Saud Medical City
For direct contact, visit the study record on ClinicalTrials.gov .